Lisianyĭ M I
Fiziol Zh (1994). 2013;59(3):126-34.
Mesenchymal stem cells (MSC) are found in a variety of tissues, including bone marrow, skin and adipose tissue and can be expanded easily in vitro. MSC are thought to have tissue regenerative properties, in the first place via their multilineage differentiation capacity. In addition, MSC have potent immunomodulatory capacity. They inhibit the proliferation of T cells and inhibit dendritic cell maturation. These properties make MSC promising for a diversity of clinical applications; for example, for the prevention and treatment of autoimmune diseases and bone marrow rejection. Different studies have attributed the immunosuppressive effect of MSC to different immunosuppressive factors. These include indoleamine 2,3-dioxygenase (IDO), HLA-G, nitric oxide, interleukines. The long-term ability of allogeneic MSCs to preserve function in the infarcted heart is limited by a biphasic immune response whereby they transition from an immunoprivileged to an immunogenic state after differentiation, which is associated with an alteration in major histocompatibility complex--immune antigen profile. These findings provide critical information about the immunosuppression of MSCs and for better application of MSCs in treating immune disorders.
间充质干细胞(MSC)存在于多种组织中,包括骨髓、皮肤和脂肪组织,并且能够在体外轻松扩增。人们认为MSC具有组织再生特性,首先是通过其多向分化能力。此外,MSC具有强大的免疫调节能力。它们抑制T细胞增殖并抑制树突状细胞成熟。这些特性使MSC在多种临床应用中具有前景;例如,用于预防和治疗自身免疫性疾病以及骨髓排斥反应。不同的研究将MSC的免疫抑制作用归因于不同的免疫抑制因子。这些因子包括吲哚胺2,3-双加氧酶(IDO)、HLA-G、一氧化氮、白细胞介素。同种异体MSC在梗死心脏中维持功能的长期能力受到双相免疫反应的限制,即它们在分化后从免疫特权状态转变为免疫原性状态,这与主要组织相容性复合体——免疫抗原谱的改变有关。这些发现为MSC的免疫抑制作用以及更好地将MSC应用于治疗免疫紊乱提供了关键信息。